Literature DB >> 8067385

Juxtamedullary microvascular responses to arginine vasopressin in rat kidney.

L M Harrison-Bernard1, P K Carmines.   

Abstract

Experiments were performed to determine the site of arginine vasopressin (AVP)-induced vascular resistance adjustments that result in decreases in papillary blood flow. Simultaneous measurements of luminal diameter and centerline erythrocyte velocity allowed estimation of single-vessel blood flow in in vitro blood-perfused juxtamedullary nephrons. AVP (0.1-1,000 pM) caused concentration-dependent reductions in outer medullary descending vasa recta (OMDVR) blood flow (10 pM) without altering OMDVR diameter. Afferent arteriolar diameter was significantly decreased by 1 pM AVP, whereas arcuate artery diameter was decreased by 100 pM AVP. Increasing the concentration of AVP to 1,000 pM resulted in significant reductions of vessel diameter in interlobular arteries, distal afferent arterioles, and efferent arterioles. The effects of AVP to decrease afferent arteriolar diameter and blood flow were blocked in the presence of V1 receptor antagonist. These data indicate that afferent arterioles exhibit the greatest sensitivity to the vasoconstrictor effects of AVP, whereas OMDVR appear insensitive. We conclude that the change in OMDVR blood flow produced by AVP is not due to a direct effect of the peptide on this vascular segment but to its effect on upstream vessels.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8067385     DOI: 10.1152/ajprenal.1994.267.2.F249

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  10 in total

Review 1.  AKI associated with cardiac surgery.

Authors:  Robert H Thiele; James M Isbell; Mitchell H Rosner
Journal:  Clin J Am Soc Nephrol       Date:  2014-11-06       Impact factor: 8.237

2.  Tyrosine kinase involvement in renal arteriolar constrictor responses to angiotensin II.

Authors:  P K Carmines; R W Fallet; Q Che; K Fujiwara
Journal:  Hypertension       Date:  2001-02       Impact factor: 10.190

3.  Relative contributions of Ca2+ mobilization and influx in renal arteriolar contractile responses to arginine vasopressin.

Authors:  Rachel W Fallet; Hideki Ikenaga; Joseph P Bast; Pamela K Carmines
Journal:  Am J Physiol Renal Physiol       Date:  2004-11-09

4.  Exaggerated impact of ATP-sensitive K(+) channels on afferent arteriolar diameter in diabetes mellitus.

Authors:  Hideki Ikenaga; Joseph P Bast; Rachel W Fallet; Pamela K Carmines
Journal:  J Am Soc Nephrol       Date:  2000-07       Impact factor: 10.121

Review 5.  Role of vasopressin in the management of septic shock.

Authors:  Gökhan M Mutlu; Phillip Factor
Journal:  Intensive Care Med       Date:  2004-04-21       Impact factor: 17.440

6.  Clinical impact of vasopressin infusion on hemodynamics, liver and renal function in pediatric patients.

Authors:  Nameet Jerath; Helena Frndova; Brian W McCrindle; Rebecca Gurofsky; Tilman Humpl
Journal:  Intensive Care Med       Date:  2008-03-19       Impact factor: 17.440

Review 7.  Clinical review: Vasopressin and terlipressin in septic shock patients.

Authors:  Anne Delmas; Marc Leone; Sébastien Rousseau; Jacques Albanèse; Claude Martin
Journal:  Crit Care       Date:  2004-09-09       Impact factor: 9.097

8.  Vasopressin vs Terlipressin in Treatment of Refractory Shock.

Authors:  G Scarpati; O Piazza
Journal:  Transl Med UniSa       Date:  2013-01-04

Review 9.  Renal pericytes: regulators of medullary blood flow.

Authors:  T M Kennedy-Lydon; C Crawford; S S P Wildman; C M Peppiatt-Wildman
Journal:  Acta Physiol (Oxf)       Date:  2012-11-06       Impact factor: 6.311

10.  Role of vasopressin in the treatment of anaphylactic shock in a child undergoing surgery for congenital heart disease: a case report.

Authors:  Luca Di Chiara; Giulia V Stazi; Zaccaria Ricci; Angelo Polito; Stefano Morelli; Chiara Giorni; Ondina La Salvia; Vincenzo Vitale; Eugenio Rossi; Sergio Picardo
Journal:  J Med Case Rep       Date:  2008-02-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.